Results 41 to 50 of about 85,805 (344)
Glycosaminoglycans: From Vascular Physiology to Tissue Engineering Applications
Frontiers in Chemistry, 2021 Cardiovascular diseases represent the number one cause of death globally, with atherosclerosis a major contributor. Despite the clinical need for functional arterial substitutes, success has been limited to arterial replacements of large-caliber vessels (
Antonio Junior Lepedda +5 more
doaj +1 more source
Influence of combined nitrate and fluoride intoxication on connective tissue disorders in rats gastric mucosa [PDF]
Archives of the Balkan Medical Union, 2019 Introduction. Certain regions in Europe and Ukraine have high concentration of fluorides in drinking waters. Highly developed agriculture can result in increased concentration of nitrates in ground and drinking waters. Therefore, their combined excessive
Oleh Y. AKIMOV +2 more
doaj +1 more source
Interaction of Zika Virus Envelope Protein with Glycosaminoglycans.
Biochemistry, 2017 In February 2016, the World Health Organization declared a Public Health Emergency of International Concern on Zika Virus (ZIKV), because of its association with severe fetal anomalies of congenitally infected humans.
S. Kim +8 more
semanticscholar +1 more source
Chemokine‐Capturing Wound Contact Layer Rescues Dermal Healing
Advanced Science, 2021 Excessive inflammation often impedes the healing of chronic wounds. Scavenging of chemokines by multiarmed poly(ethylene glycol)‐glycosaminoglycan (starPEG‐GAG) hydrogels has recently been shown to support regeneration in a diabetic mouse chronic skin ...
Lucas Schirmer +3 more
doaj +1 more source
The glycosaminoglycans of human plasma [PDF]
Journal of Clinical Investigation, 1969 A method is proposed for the measurement of glycosaminoglycans (GAG) on 5-10 ml of plasma. It is based on the adsorption of GAG on small ECTEOLA columns followed by measurement of the hexuronic acid in the NaCl eluates. Routine use of the method has indicated the presence of a GAG fraction that adsorbs readily on ECTEOLA ("free" GAG) and of another ...
CALATRONI, Alberto +2 more
openaire +4 more sources
Metabolites, 2023 Mucopolysaccharidosis 1 (MPS 1) is a group of rare lysosomal genetic disorders resulting from the accumulation of undegraded glycosaminoglycans (GAGs) leading to multiorgan damage. Neurological symptoms vary from mild to severe.
Magdalena Machnikowska-Sokołowska +5 more
doaj +1 more source
Ecotoxicology and Environmental Safety, 2022 The objective of this study was to investigate the effects of exposure to endotoxin on the reproductive performance of humans and animals in pregnancy and delivery period.
Ming-ming Zhang +7 more
doaj
Frontiers in Endocrinology, 2018 Background: The process of testicular descent requires androgen and insulin-like 3, hormones secreted by fetal Leydig cells. Knowledge concerning distinct and common functions of these hormones in regulating development of the fetal gubernaculum remains ...
Joshua T. Morgan +7 more
doaj +1 more source
Frontiers in Immunology, 2019 A very common mechanism to trap pathogens is the release of DNA. Like flies in a spider's web, pathogens are enclosed in a sticky chromatin meshwork. Interestingly, plants already use this mechanism to catch bacteria.
Kim F. Bornhöfft, Sebastian P. Galuska
doaj +1 more source
Diagnostics, 2021 Mucopolysaccharidoses (MPS) and mucolipidosis (ML II/III) are a group of lysosomal storage disorders (LSDs) that occur due to a dysfunction of the lysosomal hydrolases responsible for the catabolism of glycosaminoglycans (GAGs).
Nivethitha Arunkumar +14 more
doaj +1 more source